Literature DB >> 27508104

Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical use.

Pedram Heidari1, Alicia Szretter1, Laura E Rushford1, Maria Stevens1, Lee Collier1, Judit Sore1, Jacob Hooker1, Umar Mahmood1.   

Abstract

The interest in (68)Gallium labeled PET probes continues to increase around the world. Widespread use in Europe and Asia has led to great interest for use at numerous sites in the US. One barrier to entry is the cost of the automated synthesis units for relatively simple labeling procedures. We describe the construction and testing of a relatively low-cost automated (68)Ga-labeling unit for human-use. We provide a guide for construction, including part lists and synthesis timelists to facilitate local implementation. Such inexpensive systems could help increase use around the globe and in the US in particular by removing one of the barriers to greater widespread availability. The developed automated synthesis unit reproducibly synthesized (68)Ga-DOTATOC with average yield of 71 ± 8% and a radiochemical purity ≥ 95% in a synthesis time of 25 ± 1 minutes. Automated product yields are comparable to that of manual synthesis. We demonstrate in-house construction and use of a low-cost automated synthesis unit for labeling of DOTATOC and similar peptides with (68)Gallium.

Entities:  

Keywords:  68Gallium; DOTATOC; automated synthesis; peptide labeling

Year:  2016        PMID: 27508104      PMCID: PMC4965522     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  11 in total

1.  Radiolabelling DOTA-peptides with 68Ga.

Authors:  Wouter A P Breeman; Marion de Jong; Erik de Blois; Bert F Bernard; Mark Konijnenberg; Eric P Krenning
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01-18       Impact factor: 9.236

Review 2.  68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.

Authors:  Melpomeni Fani; João P André; Helmut R Maecke
Journal:  Contrast Media Mol Imaging       Date:  2008 Mar-Apr       Impact factor: 3.161

3.  Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification.

Authors:  M Ocak; M Antretter; R Knopp; F Kunkel; M Petrik; N Bergisadi; C Decristoforo
Journal:  Appl Radiat Isot       Date:  2009-10-24       Impact factor: 1.513

4.  Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.

Authors:  Erik de Blois; Ho Sze Chan; Clive Naidoo; Deidre Prince; Eric P Krenning; Wouter A P Breeman
Journal:  Appl Radiat Isot       Date:  2010-11-23       Impact factor: 1.513

5.  Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.

Authors:  Pedram Heidari; Francis Deng; Shadi A Esfahani; Alicia K Leece; Timothy M Shoup; Neil Vasdev; Umar Mahmood
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

6.  Processing of generator-produced 68Ga for medical application.

Authors:  Konstantin P Zhernosekov; Dimitry V Filosofov; Richard P Baum; Peter Aschoff; Heiner Bihl; Anatoli A Razbash; Markus Jahn; Mark Jennewein; Frank Rösch
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

7.  A container closure system that allows for greater recovery of radiolabeled peptide compared to the standard borosilicate glass system.

Authors:  Alicia K Leece; Pedram Heidari; Daniel L Yokell; Umar Mahmood
Journal:  Appl Radiat Isot       Date:  2013-06-24       Impact factor: 1.513

8.  A fully automated synthesis for the preparation of 68Ga-labelled peptides.

Authors:  Clemens Decristoforo; Roger Knopp; Elisabeth von Guggenberg; Marco Rupprich; Thorsten Dreger; Andre Hess; Irene Virgolini; Roland Haubner
Journal:  Nucl Med Commun       Date:  2007-11       Impact factor: 1.690

9.  Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

Authors:  Pedram Heidari; Eric Wehrenberg-Klee; Peiman Habibollahi; Daniel Yokell; Matthew Kulke; Umar Mahmood
Journal:  Cancer Res       Date:  2013-09-30       Impact factor: 12.701

10.  THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.

Authors:  Richard P Baum; Harshad R Kulkarni
Journal:  Theranostics       Date:  2012-05-07       Impact factor: 11.556

View more
  4 in total

1.  A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68Ga-DOTATOC in healthy volunteers.

Authors:  Shadi A Esfahani; Stephanie Salcedo; Pedram Heidari; Onofrio A Catalano; Rachel Pauplis; Jacob Hesterman; James F Kronauge; Umar Mahmood
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-04-15

2.  [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

Authors:  Rutger Mahieu; Gerard C Krijger; F F Tessa Ververs; Remmert de Roos; Remco de Bree; Bart de Keizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04       Impact factor: 9.236

3.  Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.

Authors:  Pedram Heidari; Anchisa Kunawudhi; Jordi Martinez-Quintanilla; Alicia Szretter; Khalid Shah; Umar Mahmood
Journal:  Theranostics       Date:  2018-05-23       Impact factor: 11.556

Review 4.  18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.

Authors:  Rudolf A Werner; Thorsten Derlin; Constantin Lapa; Sara Sheikbahaei; Takahiro Higuchi; Frederik L Giesel; Spencer Behr; Alexander Drzezga; Hiroyuki Kimura; Andreas K Buck; Frank M Bengel; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.